Posts

Jefferson Lab hosts International Computing in High Ene...

NEWPORT NEWS, VA – Experts in high-performance computing and data management are...

Archaea in a warming climate become less diverse, more ...

Led by Jizhong Zhou, Ph.D., the director of the Institute for Environmental Geno...

Systemic AL amyloidosis: Current approach and future di...

“AL amyloidosis is a fatal disease and systemic therapy is required to prevent d...

nTIDE April 2023 Jobs Report: Despite sharp decline, em...

East Hanover, NJ – May 5, 2023 –Declines in the April job numbers for people wit...

IOF Young Investigators Nutrition Research Grants award...

Nutritional and dietary factors have an enormous impact on health, with musculos...

Book examines the effects of volatility in state fundin...

CHAMPAIGN, Ill. — With rampant inflation and some financial gurus forecasting an...

Smart surgical implant coatings provide early failure w...

CHAMPAIGN, Ill. — Newly developed “smart” coatings for surgical orthopedic impla...

Markey Cancer Center earns National Pancreas Foundation...

LEXINGTON, Ky. (May 5, 2023) — The University of Kentucky Markey Cancer Center h...

Artificial intelligence identifies anti-aging drug cand...

SAN CARLOS, California – A new publication in the May issue of Nature Aging by r...

Travere Therapeutics’ Drug Approved for One Rare Kidney...

Travere Therapeutics is a startup that mainly focuses on rare forms of diseases....

J&J Strikes a $245 CAR-T Deal With Cellular Biomedicine

Johnson & Johnson’s Janssen Biotech subsidiary has just paid $245 million upfron...

Understanding the current and future state of complex h...

The recent proliferation of digital health has led to data privacy concerns arou...

FDA grants GSK first-ever approval for RSV vaccine

Amidst steep competition, GSK’s Arexvy becomes the first approved vaccine worldw...

Forge Biologics and Labcorp partner for gene therapies ...

The collaboration will reduce constraints related to analytical development and ...

ARTHEx Biotech raises funds to advance DM1 therapy to c...

ATX-01 has a dual mechanism of action that targets toxic DMPK and MBNL proteins.

Roche opens new institute to advance research in human ...

Human model systems are tiny 2D or 3D living replicas of human tissues and organ...